No abstract available
MeSH terms
-
Administration, Topical
-
Adult
-
Aged
-
Angiogenesis Inhibitors / administration & dosage*
-
Angiogenesis Inhibitors / adverse effects
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal, Humanized
-
Bevacizumab
-
Corneal Neovascularization / drug therapy*
-
Corneal Neovascularization / physiopathology
-
Epithelium, Corneal / drug effects
-
Epithelium, Corneal / pathology
-
Female
-
Humans
-
Intraocular Pressure / drug effects
-
Male
-
Middle Aged
-
Prognosis
-
Tonometry, Ocular
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Visual Acuity / drug effects
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Bevacizumab